Antiphospholipid syndrome (APS) based on a history of recurrent miscarriage (APS/RM): The importance of cytogenetic analysis

被引：0
|
作者：
Stephenson, M. D.
Wu, S.
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
[2] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2007年 / 25卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：150 / 151
页数：2
相关论文
共 50 条
  • [21] Studies of microparticles in patients with antiphospholipid syndrome (APS)
    Vikerfors, A.
    Mobarrez, F.
    Bremme, K.
    Holmstrom, M.
    Agren, A.
    Eelde, A.
    Bruzelius, M.
    Antovic, A.
    Wallen, H.
    Svenungsson, E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 626 - 626
  • [22] Anticoagulation in a patient with catastrophic antiphospholipid syndrome (APS)
    Serre, A. F.
    Ruivard, M.
    Berger, M. G.
    Marques-Verdier, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1178 - 1178
  • [23] Adrenal insufficiency complicated with antiphospholipid syndrome (APS)
    Fujishima, Naohito
    Komatsuda, Atsushi
    Ohyagi, Hideaki
    Fujishima, Masumi
    Tada, Mitsunori
    Ohtani, Hiroshi
    Wakui, Hideki
    Hirokawa, Makoto
    Sawada, Ken-ichi
    INTERNAL MEDICINE, 2006, 45 (16) : 963 - 966
  • [24] The efficacy of specific IVIG in antiphospholipid syndrome (APS): Trophoblast invasiveness and APS animal model
    Blank, M.
    Anafi, L.
    Zandman-Goddard, G.
    Goldman, S.
    Shalev, E.
    Cervera, R.
    Font, J.
    Fridkin, M.
    Shoenfeld, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 303 - 304
  • [25] Increased eryptosis in patients with primary antiphospholipid syndrome (APS): a new actor in the pathogenesis of APS
    Vomero, M.
    Finucci, A.
    Barbati, C.
    Colasanti, T.
    Ceccarelli, F.
    Novelli, L.
    Massaro, L.
    Truglia, S.
    Pensa, C.
    Mauro, F. R.
    Foal, R.
    Valesini, G.
    Conti, F.
    Alessandri, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (04) : 838 - 843
  • [26] New subsets of the antiphospholipid syndrome in 2006: "PRE-APS" (probable APS) and microangiopathic antiphospholipid syndromes ("MAPS")
    Asherson, Ronald A.
    AUTOIMMUNITY REVIEWS, 2006, 6 (02) : 76 - 80
  • [27] Evidence-based classification criteria for antiphospholipid antibo syndrome (APS).
    Petri, M
    Akhtar, S
    Branch, DW
    Brey, RL
    Lockshin, A
    Roubey, R
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S364 - S364
  • [28] Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions
    Cervera, R.
    Tektonidou, M. G.
    Espinosa, G.
    Cabral, A. R.
    Gonzalez, E. B.
    Erkan, D.
    Vadya, S.
    Adrogue, H. E.
    Solomon, M.
    Zandman-Goddard, G.
    Shoenfeld, Y.
    LUPUS, 2011, 20 (02) : 165 - 173
  • [29] Antiphospholipid syndrome (APS) nephropathy in catastrophic, primary, and systemic lupus erythematosus-related APS
    Tektonidou, Maria G.
    Sotsiou, Flora
    Moutsopoulos, Haralampos M.
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (10) : 1983 - 1988
  • [30] THROMBOTIC CEREBRAL ARTERIOPATHY IN PATIENTS WITH THE ANTIPHOSPHOLIPID SYNDROME (APS)
    HUGHSON, MD
    MCCARTY, GA
    SHOLER, C
    BRUMBACK, RA
    LABORATORY INVESTIGATION, 1993, 68 (01) : A24 - A24
12345